The Dempze Nancy E Raises Stake in Roche Holding Ltd. (RHHBY), Report finds

The Dempze Nancy E Raises Stake in Roche Holding Ltd. (RHHBY), Report finds

Other institutional investors have also recently modified their holdings of the company. Williams Jones & Associates LLC increased its position in Roche Holding by 27,884.8% in the second quarter. Williams Jones & Associates LLC now owns 1,119,391 shares of the company’s stock valued at $36,884,000 after buying an additional 1,115,391 shares during the last quarter. Mairs & Power INC increased its position in Roche Holding by 15.9% in the third quarter. Mairs & Power INC now owns 4,644,431 shares of the company’s stock valued at $143,838,000 after buying an additional 638,829 shares during the last quarter. Schafer Cullen Capital Management Inc. increased its position in Roche Holding by 4.4% in the third quarter. Schafer Cullen Capital Management Inc. now owns 2,505,900 shares of the company’s stock valued at $77,608,000 after buying an additional 106,037 shares during the last quarter. Hikari Power Ltd increased its position in Roche Holding by 23.8% in the third quarter. Hikari Power Ltd now owns 234,500 shares of the company’s stock valued at $7,262,000 after buying an additional 45,100 shares during the last quarter. Finally, Norman Fields Gottscho Capital Management LLC increased its position in Roche Holding by 447.9% in the third quarter. Norman Fields Gottscho Capital Management LLC now owns 54,650 shares of the company’s stock valued at $1,693,000 after buying an additional 44,675 shares during the last quarter.

Dempze Nancy E boosted its stake in Roche Holding Ltd. (NASDAQ:RHHBY) by 1.5% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 23,365 shares of the company’s stock after buying an additional 335 shares during the period. Roche Holding comprises approximately 1.3% of Dempze Nancy E’s portfolio, making the stock its 29th largest position. Dempze Nancy E’s holdings in Roche Holding were worth $724,000 as of its most recent filing with the SEC.

Shares of Roche Holding Ltd. (NASDAQ:RHHBY) opened at 29.996 on Monday. The stock has a 50 day moving average price of $29.40 and a 200-day moving average price of $29.82. The stock has a market cap of $204.44 billion and a P/E ratio of 21.370. Roche Holding Ltd. has a 12 month low of $25.25 and a 12 month high of $33.77.

Several research firms have weighed in on RHHBY. Sanford C. Bernstein reissued an “overweight” rating on shares of Roche Holding in a research report on Wednesday, December 7th. Zacks Investment Research downgraded Roche Holding from a “hold” rating to a “strong sell” rating in a research report on Monday, October 17th.

Roche Holding Company Profile

Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding Ltd. (NASDAQ:RHHBY).

Related posts

Leave a Comment